In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price ...
Even after a flurry of corporate updates during the first two days of the J.P. Morgan Healthcare Conference, many more ...
During JPM week, virtual care companies strut their plans to make GLP-1 drugs work harder, cost less
Digital health companies' plans focused on managing the impact of GLP-1 drugs, which have placed enormous pressure on health ...
Radiance Biopharma, Inc. a biotechnology company developing next generation Antibody Drug Conjugates (“ADCs”) and Bispecific ADCs (“BsADCs), announced that it has been selected to participate in Seed ...
LONDON - J.P. Morgan Securities PLC has announced its role as the Stabilisation Coordinator for Bapco Energies Sukuk ...
JPMorgan Chase & Co. (NYSE: JPM) ("JPMorganChase" or the "Firm") has declared dividends on the outstanding shares of the Firm ...
While Biogen has made an opportunistic bid for partner Sage, its top executive seemed to play down the urgency for his ...
Medicare Advantage (MA) insurers Alignment Healthcare and Clover Health both reported increased membership growth ahead of ...
The current head of the Center for Medicare has advice for her successor: "Engaging everyone in the ecosystem" is the ...
The pharma began submitting its TAR-200 bladder cancer treatment to the FDA. Elsewhere, Sarepta and Madrigal reported strong ...
Secure your spot in South Africa's premier corporate fitness event, set for March 13, 2025, at the Wanderers Club.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback